Urogen Pharma Ltd is a biotechnology company focused on developing and commercializing innovative therapies for treating uro-oncological diseases

The company specializes in the research and development of novel drug formulations that target bladder cancer and other urological conditions, aiming to address significant unmet medical needs. With a commitment to advancing patient care, Urogen leverages its proprietary technology platforms to create transformative treatment options that enhance patient outcomes and improve the quality of life for individuals affected by these serious conditions.